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Objective
This study investigates the course of serum cytokine levels in patients with multiple trauma, 
patients with a ruptured abdominal aortic aneurysm (AAA), and patients undergoing elective AAA 
repair and the relationship of these cytokines to the development of adult respiratory distress 
syndrome (ARDS) and multiple organ failure (MOF).
Summary Background Data
Severe tissue trauma, hemorrhagic shock, and ischemia-reperfusion injury are pathophysiologic 
mechanisms that may result in an excessive uncontrolled activation of inflammatory cells and 
mediators. This inflammatory response is thought to play a key role in the development of 
(remote) cell and organ dysfunction, which is the basis of ARDS and MOF.
Methods
The study concerns 28 patients with multiple trauma, 20 patients admitted in shock because of a 
ruptured AAA, and 18 patients undergoing elective AAA repair. Arterial blood was serially sampled 
from admission (or at the start of elective operation) to day 13 in the intensive care unit, and the 
serum concentrations of tumor necrosis factor-iv (TNF-a), interleukin (IL)-1jtf, and IL-6 were 
determined.
Results
Twenty-two patients died, 15 within 48 hours and 7 after several weeks, as a result of ARDS/MOF. 
At hospital admission and after 6 hours, these nonsurvivors had significantly higher plasma TNF-cv 
and IL-10 levels than did the survivors. At the same measuring points, TNF-o: and IL-1/3 were 
significantly more elevated in patients with ruptured AAA than in traumatized patients. However, 
IL-6 was significantly higher in the traumatized patients. In 10 patients, ARDS/MOF developed, 
and 41 had an uncomplicated course in this respect. Those with ARDS/MOF exhibited 
significantly different cytokine patterns in the early postinjury phase. TNF-a and IL-10 levels were 
higher mainly on the first day of admission; IL-6 concentrations were significantly elevated in
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patients with ARDS/MOF from the second day onward. The latter cytokine showed a good 
correlation with the daily MOF score during the whole 2-week observation period.
Conclusions
In the early postinjury phase, higher concentrations of these cytokines are associated, not only 
with an increased mortality rate, but also with an increased risk for subsequent ARDS and MOF. 
These data therefore support the concept that these syndromes are caused by an overwhelming 
autodestructive inflammatory response.
Evidence is accum ula t ing  that  adult  respiratory dis­
tress syndrom e (ARDS) and  multip le  organ failure 
(M O F) are the result o f  a severe generalized au todes truc­
tive in f lam m ation , in which m icroorganism s may or 
m ay not be involved.' T ra u m a ,  shock, and  infection ini- 
tiate a com plex in f lam m atory  response, in which the 
proin flam m atorv  cytokines tu m o r  necrosis factor-« 
(T N F -a) ,  in terleukin  ( IL ) - l (3, and  IL-6 are thought to 
play a pivotal roIe.~” T he  role o f  these cytokines has al­
most exclusively been studied in relation to the p a th o ­
genesis o f  infection and  septic shock. Only  a few studies 
deal with cy tok inem ia  after t r a u m a  or hem orrhagic  
sh o ck .5" 10 Most o f  these— clinical and  exper im en ta l—  
studies have death  as their end point. However, A R D S 
and  M O F  represent an im p o r tan t  part o f  the m orbid ity  
incidence in the intensive care unit (ICU), being respon­
sible for m ore  than  70% o f  the ventila tor days spent on 
the IC U . 1 1 112 In addition , A R D S  and  M O F  are the m ain  
cause o f  late death  in surgical ICU patients  and  put a 
heavy burden  on health ca re . 12 Therefore, unraveling the 
pathophysiology o f  these syndrom es should be a m ajor  
objective o f  study. W e investigated the role o f  circulating 
cytokines (T N F -a ,  I L - 1/3, and  IL-6 ) in relation to the de­
ve lopm ent o f  A R D S  and  M O F  in patients after essen­
tially nonbacteria l challenges, tha t  is, severe b lunt 
t raum a , hem orrhag ic  shock, and  m ajo r  vascular surgery.
PATIENTS AND METHODS
Sixty-six patients  were studied prospectively, inc lud­
ing 18 patients  undergoing  elective aortic surgery (16 
with abdom ina l  aortic  aneu rysm s  [AAA] and  2 with 
tho raco ab d o m in a l  aortic  aneurysm s), 20 patients  with 
hem orrhag ic  shock because o f  a rup tu red  AAA, and  28 
patients  with severe b lun t  t r a u m a  (hospital t r a u m a  index 
injury severity score [ISS] >  2 5 ) .13,14 All patients  or their 
relatives gave inform ed consent to draw  blood for the 
analvses.
Arterial blood was w ithdraw n from the patients un-
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dergoing elective aortic surgery at the t im e o f  the inci­
sion, when they had already been anesthetized (0 hours) 
and  after 6 and 24 hours. Subsequently , samples were 
collected daily during  the first week and  every o ther  day 
during  the second week, as long as the patients  were in 
the ICU, with a m a x im u m  o f  2 weeks. For the o ther  pa­
tients, the first sam pling po in t  (0 hours) was im m ediate ly  
after hospital admission. Thereafter,  the sam e schedule 
was followed as for the patients  with elective surgery.
Definitions
An A P A C H E  II sco re1'' was calculated for all patients  
at the t im e o f  hospital and  subsequen t ICU adm ission 
and, thereafter, daily th roughou t  the ICU stay. T o  grade 
the intensity o f  organ failure, a daily M O F  score was cal­
culated. 1 T h e  patien t 's  condit ion  was diagnosed as M O F  
if the average M O F  score between days 5 and  14 was > 
4 . 16 A R D S  was diagnosed when patients  had bilateral 
diffuse infiltrates on chest radiography and  progressive 
hypoxem ia  requiring mechanical ventilation, resulting 
in an arterial oxygen tens ion -frac t ion  o f  inspired oxygen 
ratio <  175 with P E E P >  10 c m H :0  and, in cases o f  prior 
cardiac disease, did not have a p u lm o n ary  artery wedge 
pressure exceeding 18 m m H g . 17
A shock score was defined to grade the severity o f  he­
m o d y n a m ic  derangem en t after ad m iss io n . 16 For this 
purpose, the A llgow erls shock index (heart frequency/ 
systolic blood pressure) and  the systolic blood pressure 
were used as follows: 0 or no shock, index <  1.0 and  sys­
tolic blood pressure > 100 m m H g ; 1 or mild, c o m p e n ­
sated shock, index >  1.0 and  systolic blood pressure > 
100 m m H g; 2 or m odera te  shock, systolic blood pressure 
80 to 100 m m H g ; 3 or severe shock, systolic blood pres­
sure <  80 m m H g ; 4 or severe, prolonged shock, m ore  
than  1-hour systolic blood pressure <  80 m m H g.
Blood Analysis
Arterial blood was collected in sterile 4 -m L  tubes c o n ­
ta in ing  0.048 m L  o f  e thylene d iam in e  tetra-acetate  (Vac- 
u ta iner  Systems, Becton D ickinson, R utherford ,  NJ) 
and  250 f±L o f  ap ro tin in  (final concen tra t ion ,  625 kalli- 
krein inactivating u n i ts /m L , Bayer, Leverkusen, G e r ­
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many). After centrifugation at 2000 X g  for 10 minutes, 
the resulting platelet poor  p lasm a was transferred into 
sterile l .5 -m L  tubes, and  the samples were stored at 
- 2 0 ° C  until further analysis. T h e  samples were analyzed 
by fluid-phase rad io im m unoassay  for TNF-a ' and  IL -10, 
as described prev iously .1920 Before the \ L - \ f i  m easure­
m ent,  the p lasm a was extracted with chloroform  accord­
ing to a published m e th o d .20 T he  detection levels in 
the assays were as follows: T N F -a ,  60 pg /m L; IL-1/?, 
200 pg /m L.
Arterial blood for the IL-6 assay was collected in sterile 
4 -m L  tubes and  processed as described earlier. IL-6 was 
quantified by an enzym e-linked im m u n o so rb e n t  assay. 
M icrotiter  flat-bottom plates (Costar. T he  Netherlands) 
were coated with anti-IL-6 m onoclona l  (M oab) BE-8 (7 
¿ig/mL) in phosphate-buffered saline (PBS), pFI 7.4 (100 
¿¿L/well). After a 24 -hour  incubation  at 4 C, the plates 
were washed with PBS with 0.02% (v/v) Tween-20, fol­
lowed by a 60 -m inu te  room  tem pera tu re  incubation  o f  
PBS with 5% bovine serum  a lb u m en  (BSA) (200 f iL /  
well). After washing, serial d ilu tions o f  s tandard  recom ­
b inan t  h u m a n  IL-6 (a kind gift o f  Dr. L. Aarden, CLB, 
A m ste rdam , T he  N etherlands) or the serum  samples 
were added  to the plates, and  incubation  proceeded for 1 
h o u r  at 37 C. After washing, 100 /¿L o f  PBS/BSA with 
biotinylated anti-IL-6 M oab  BE-4 (2 f ig /m L ) was added 
to the wells. BE-4 and  BE-8 recognize different epitopes. 
After a 60 -m inu te  incubation  and  a washing step, 100 ¿uL 
o f  strepavidin horseradish peroxidase in PBS/BSA was 
added, followed by a 4 5 -m in u te  incubation . After w ash­
ing, a citric acid buffer, pH 5.2, with 0.003% hydrogen 
peroxide and  o r tho -phenv ld iam ine  was added. T he  reac­
tion was te rm ina ted  with 4 N sulfuric acid, and  the ab ­
sorbance was read at 495 n m  in an au to m a ted  enzym e- 
linked im m u n o so rb e n t  assay reader (Titertek, T he  N e th ­
erlands). T he  detection level o f  this assay was 20 pg/m L. 
T he  arterial blood lactate was m easured  in deprotein ized 
sam ples (0.6 N perchloric acid) by enzym atic  conversion 
o f  the lactate into  pyruvate.
Statistical Analysis
T h e  K ruska l-W all is  test and  the W ilcoxon tw o-sam ­
ple test were used to exam ine  differences between patient 
groups when indicated. S p ea rm an 's  correlation coeffi­
cients were used for correlation analysis. W e considered 
p values <  0.05 to be significant.
RESULTS
D em ograph ic  da ta  for the 66 patients  are presented in 
Table  1. W e differentiated between early (the first or sec­
ond  day o f  adm ission) and  late death. Fifteen patients 
(eight with t r a u m a  and  seven with rup tu red  AAAs) died
early. O f  the rem ain ing  51 patients, in 10, A R D S /M O F  
developed. Tw o traum atized  patients had A R D S  w ith­
out subsequent M O F  and  survived. O ne patient with a 
rup tu red  AAA had A R D S w ithout M O F  and also sur­
vived. T he  rem ain ing  seven patients all had M O F  (six 
including ARDS), and  they died on days 28 to 60 in the 
ICU. Thus, the total n u m b e r  o f  deaths was 22 in 66 pa­
tients (33%>). T he  41 survivors who did not have A R D S / 
M O F  were considered to be patients  with an u n co m p li­
cated clinical course.
T he  course o f  the cytokine concen tra t ions  during  the 
first 2 days in the three patients groups is depicted in Fig­
ure 1. O n admission, IL-1 (3 and , after 6 hours, TNF-cv 
levels were at a significantly higher level in patients with 
rup tu red  AAAs com pared  with the traum atized  patients 
(p = 0.03 and  0.02, respectively). In this early postin jury 
period (0 hours), however, the IL-6 level was significantly 
m ore elevated in the traum atized  patients com pared  
with both vascular patient groups (p <  0.001). O n days 1 
and  2, the differences between groups in regard to T N F -  
a  and  IL-l/ j  levels disappeared, bu t IL-6 concen tra t ions  
were increased in the vascular patient groups. In the t r a u ­
matized patients, a decrease was observed.
Figure 2 illustrates the course o f  cytokine co n cen tra ­
tions during  the first day o f  adm ission in relation to 
death. T he  corresponding  p values o f  these m easure­
m ents  are listed in table 2. N onsurvivors  had signifi­
cantly higher T N F - a  and  IL-1 (3 concentra tions, both on 
adm ission and 6 hours  later. W ith respect to I L - 1 t h i s  
difference was mainly caused by the con tr ibu t ion  o f  the 
late nonsurvivors  who died o f  A R D S /M O F ;  in the case 
o f  T N F -a ,  both early and  late nonsurvivors  appeared  to 
con tr ibu te  equally to the observed difference with survi­
vors. T he  differences in IL-6 concen tra t ions  between 
nonsurvivors  and  survivors did not reach statistical sig­
nificance (p = 0.07 and  0.08 at 6 and  24 hours, respec­
tively). In addition , we did not find any significant 
difference in cytokine concen tra t ions  between early and 
late nonsurvivors.
Figure 3 shows the course o f  the cytokine concen tra ­
tions during  the first 2 weeks in the ICU in the group o f
10 patients with A R D S /M O F  and  the 41 patients  with 
an uncom plica ted  course. T he  IL-1 (3 level was increased 
in patients  with A R D S /M O F  at 6 hours  and  at the end 
o f  day 1, bu t the difference did not reach statistical sig­
nificance (p = 0.056 and  0.087, respectively). This  
difference completely  d isappeared  between days 2 and  4 
because the uncom plica ted  patients  had a rise in IL-1 ¡5 
concentra tions.  In the subsequent period, IL -l/ j  levels 
decreased again in the uncom plica ted  group, bu t  the lev­
els rem ained  elevated in the patients  with A R D S /M O F .
T N F  -a  showed a som ew hat similar picture. T here  was 
a significant difference in T N F - a  levels at 6 hours  (p <  
0.005) and  an a lm ost significant difference between days
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Table 1. DEMOGRAPHIC DATA OF THE STUDY POPULATION
Age
N (yr)
Sex
(F/M)
APACHE II 
on ICU 
Admission
Injury
Severity
Score
Early 
Death 
(<48 hr)
ARDS
and/or
MOF
Late 
Death 
(>48 hr) Uncomplicated
Elective 18 64 ±11 3/15 6.2 ±4.0 ■ 0 3 3 15
Ruptured 20 70 ± 7 1/19 11.6 ±5.4 7 5 4 8
Trauma 28 31 ±14 6/22 9.9 ± 7.0 38 ± 11 8 2 0 18
Total 66 10/56 15 10 7 41
MOF = multiple organ failure
Values are mean ± SD.
l and 2 (p = 0.055 and 0.05 l, respectively). During the 
second week, TNF-a levels rose in patients with ARDS/ 
MOF and tended to normalize in the uncomplicated pa­
tient group.
The IL-6 levels followed a completely different course. 
At all measuring points, the IL-6 concentrations were 
significantly higher in the patients with ARDS/MOF 
than in the uncomplicated patients, except for the first
24 hours, because of their large variations.
A good correlation was found between the ISS score 
and IL-6 levels on admission and 6 and 24 hours later (r 
= 0.52, 0.43, and 0.53, respectively; all p < 0.05). A 
highly significant correlation (r = 0.83, p < 0 .001) was 
found between IL-6 levels and lactate concentrations at
24 hours. Further correlation analysis between cytokines 
and the ISS score, shock score, lactate concentrations, or 
APACHE II score did not show any consistent pattern of 
significant correlations.
In all patients, a daily MOF score w-as calculated, and 
we correlated these values with the cvtokine levels mea- 
sured at different days. During the second week. IL-l/i 
and TNF-a showed good correlations with the MOF 
score (e.g., IL-l/3 levels on day 9 and MOF scores on day
9 [r = 0.63, p = 0.02]; IL-l¡5 levels on day I l and MOF 
score on day 13 [r = 0.68, p = 0.02]; TNF-a concentra­
tions on day 7 and MOF score on day 7 [r = 0.77, p = 
0.005]; and TNF-a levels on day 9 and MOF score on 
day 1 1 [r = 0.84. p = 0.001]).
Finally, striking correlations (all p < 0.01) were found 
between IL-6 concentrations and MOF scores from the 
second day onward (e.g., day 2, r = 0.64; day 3, r = 0.53; 
day 4, r = 0.60; day 5, r = 0.77; day 7, r = 0.77; day 9, r 
= 0.59; and day 1 1, r = 0.63).
Correlation analysis between the cytokine concentra­
tions of all samples at various time points did not reveal 
any significant correlation.
DISCUSSION
In the present study, we found intriguing differences in 
cytokine profiles between three different patient groups
representing different pathogenic conditions associated 
with an increased risk for subsequent ARDS/MOF, that 
is, severe trauma, hemorrhagic shock (ruptured AAA), 
and ischemia-reperfusion injury (elective AAA). On ad­
mission and after 6 hours, TNF-a concentrations were 
significantly higher in patients after hemorrhagic shock 
than after trauma. In the former patients, higher IL-10 
concentrations were also found on admission. These 
findings are in accordance with animal experiments 
showing that the induction of TNF-a release after 
trauma is significantly enhanced when hemorrhagic 
shock is also present.4 Apparently, shock is the main fac­
tor leading to the production and release of TNF-a by 
macrophages. Experimentally, it has also been demon­
strated that intestinal ischemia and reperfusion injury 
leads to live- to tenfold increases of circulating TNF-a 
levels21 and that hypoxia alone is a major stimulus for 
human peripheral blood monocytes to produce and se­
crete IL-1 /i and TNF-a.22
The ischemia and reperfusion injury is likely to be re­
sponsible for the elevated levels of TNF-a and IL-l/i 
found in patients after elective aortic aneurysm repair. 
However, it is unclear why, in some of these patients af­
ter induction of anesthesia and at the start of the opera­
tion, increased TNF-a and IL-l/i concentrations were 
found. The use of specific medication, such as cyclooxy- 
genase inhibitors, or the presence of chronic heart failure 
has been shown to lead to raised levels of circulating 
TNF-a.23,24 However, only one patient (TNF-a < 60 pg/ 
mL) regularly received cyclooxygenase inhibitors; one 
other patient exhibited signs of mild chronic heart failure 
(TNF-a, 1 10 pg/mL). Certainly, the role of anesthesia in 
relation to the release of these cytokines needs further 
investigation.
Our observations of increased IL-1/3 concentrations 
after major trauma are in agreement with the findings 
of another g r o u p , w h o  demonstrated short-lived IL-l/i 
responses to major surgical injury. It is more difficult to 
explain how our data relate to those of o t h e r s , wh o  
showed that the elevated number of circulating mono-
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Figure 1. Plasma cytokine concentrations in the three patient groups dur­
ing the first 2 days of admission. The data are expressed as medians in 
box plots ranging from the 25th to 75th percentile. Bars indicate the 5th 
and 95th percentiles. The dotted lines indicate the detection limit of the 
various cytokine assays. (□) trauma patients; (□) patients with a ruptured 
AAA; (□) patients after elective AAA repair. (*), 0.05 ^ p ^ 0.10; *, 0.01 ^ 
p < 0.05; *\ p < 0.01.
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Figure 2. Plasma cytokine concentrations on the first day of admission 
in survivors and nonsurvivors. The data are expressed as medians in box 
plots ranging from the 25th to 75th percentile. Bars indicate the 5th and 
95th percentiles. The dotted lines indicate the detection limit of the various 
cytokine assays. (□) survivors; (□) nonsurvivors. (*), 0.05 < p < 0.10; *, 
0.01 ^ p < 0.05; *\ p < 0.01.
cytes found postinjury were not able to produce ade­
quate amounts of IL-1/3 within the first 8 to 10 days after 
trauma. This process was attributed to elevated concen­
trations of prostaglandin E2, which downregulated TNF- 
cx and IL-1 (5 synthesis.8,9 However, it is currently unclear 
to what extent circulating monocytes contribute to the in 
vivo production of cytokines. TNF-cv and IL-6 , but not 
IL-10 , activity could only be detected in a rat model of 
major surgery and shock. 10 An explanation could be that
we used chloroform extraction20 to show IL-1 ¡3 activity. 
In addition, there may be differences between the cyto­
kine responses in rats and humans.
We found a different profile for IL-6 . Traumatized pa­
tients exhibited the highest concentrations of IL-6 di­
rectly postinjury and 6 hours later. These data support 
the idea that IL-6 production is more closely tied to soft 
tissue trauma than is that of other cytokines.4 The IL-6 
profiles observed are also in agreement with the reports 
describing a relationship between postoperative concen-
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Table 2. P VALUES OF WILCOXON TESTS 
FOR ANALYSIS OF DIFFERENCES 
BETWEEN CYTOKINE CONCENTRATIONS 
OF SURVIVORS AND NONSURVIVORS 
(INCLUDING EARLY AND LATE
NONSURVIVORS)
Time
(hr)
All
Nonsurvivors
Early 
Nonsurvivors 
(n = 15)
Late 
Nonsurvivors 
(n = 7)
IL-1/3 0 0.04* 0.32 0.007|
6 0.0011 0.26 0.004t
24 0.02* 0.15 0.10
TNF-a 0 0.003t 0.01* 0.08
6 0.002| 0.06 0.01*
24 0.67 0.12 0.15
IL-6 0 0.75 0.44 0.17
6 0.07 0.006t 0.86
24 0.08 0.18 0.29
Corresponding cytokine concentrations are demonstrated in Figure 2 
’ p <  0 .05 
t  p <  0 01.
trations of IL-6 and the magnitude of surgical 
trauma.26,27 The delay in the IL-6 peak in the patients 
with ruptured and elective AAAs might be explained by 
the fact that, in this case, IL-6 was mainly released by the 
surgical trauma of the vascular reconstruction and IL-6 
levels tend to follow TNF-a and IL-1/3 peaks after some 
delay.2,2'' It is of interest that the occurrence of shock ap­
parently did not contribute significantly to the release of 
IL-6 because we found no difference between patients 
after acute and elective major vascular surgery.
The role of translocating bacterial endotoxin in the 
production and release of the cytokines in the present 
patient population remains unclarified. In 28 individuals 
(11 with trauma, 10 with ruptured AAAs, and 7 with 
electively treated AAAs), we were able to look for blood 
endotoxin concentrations at 0, 6, 24, and 48 hours.16,28 
In 15 patients (4 with trauma, 6 with ruptured AAAs, 
and 5 with electively treated AAAs), endotoxemia could 
be detected (mostly at 0 or 6 hours), and all but two pa­
tients exhibited circulating TNF-a' levels at the same 
time (data not shown). However, in lOofthe 13patients 
without detectable circulating endotoxin levels, we also 
found increased TNF-a concentrations at one or more 
of the same time points. Thus, endotoxemia may be in­
dicative of the presence of subsequent circulating TNF- 
a, but it surely is not a prerequisite. Endotoxemia has 
been shown to occur after hemorrhagic shock, intestinal 
ischemia, and reperfusion injury and even after elective 
aortic aneurysm repair.16,21,28-3(1 but it was only rarely de­
tected in patients with multiple trauma.31 There is ample 
evidence that endotoxin induces the production and se-
1250-
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Figure 3. Plasma cytokine concentration during the first 2 weeks of ICU 
admission in 10 patients with ARDS/MOF (O ) and 41 patients without 
ARDS/MOF (#). The data are expressed as the mean ± standard error of 
the mean. (*), 0.05 < p < 0.10; *, 0.01 < p < 0.05; **, p < 0.01.
cretion of TNF-a, but it is clear that endotoxin is not 
the only factor responsible for the cytokine production 
in our patients. Various microbial and nonmicrobial fac­
tors are known to cause cytokine production.
The present data demonstrate that patients who sub­
sequently die eventually exhibit much higher levels of 
TNF-a, IL-1/3, and IL-6 in the early post-trauma phase 
than do survivors, but the finding of increased cytokine 
levels in nonsurvivors was probably not an independent 
phenomenon. The fact is that the large standard devia-
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tions indicate that the finding of elevated cytokine con­
centrations can hardly be expected to predict the prog­
nosis better in an individual patient than, for example, 
the ISS or APACHE II score would do. Nevertheless, the 
present data may help to elucidate the mechanism of in­
flammatory response to trauma and shock.
Finally, our data demonstrated a good correlation be­
tween cytokine levels and the development of ARDS and 
MOF. On the first 2 days after admission, TNF-a con­
centrations were significantly elevated in patients with 
subsequent ARDS/MOF. This finding was in agreement 
with those of previous reports, in which TNF-a levels 
were found to correlate with subsequent sepsis or septic 
episodes in patients postinjury.8-32,33 From these studies, 
however, it is not clear whether this phenomenon was 
linked to bacterial or nonbacterial sepsis because the 
presence of bacteria was not obligatory for the definition 
of sepsis in these studies. Such obscure use of the term 
sepsis and septic syndrome has already led to a lot of con­
fusion in the discussion about the relationship between 
bacterial sepsis (infection) and MOF. It would therefore 
be better to use a term like systemic inflammatory re­
sponse syndrome as was recently proposed.34
With respect to the IL-l (3 levels, there only was an in­
dication of a significant elevation in patients with subse­
quent ARDS/MOF on the first day after admission. An 
interesting finding was the rise of chloroform-extractable 
IL-10 between days 2 and 4 in the patients with an un­
complicated clinical course. A similar phenomenon was 
observed during the recovery phase in patients with me­
ningococcal infections.3'' This finding might suggest a 
protective effect of IL-l(3 that is necessary during the 
course of reconvalescence, which supports the proposi­
tion that several cytokines not only are synergistic but 
also counterregulate each other.2,36 However, this obser­
vation might also be influenced by the assay method 
used, and therefore, this phenomenon is presently being 
investigated further. Patients with ARDS/MOF, on the 
other hand, showed a trend of sustained elevated TNF-a 
and IL-1 ¡3 levels during the second week. This protracted 
cytokine release was probably associated with the organ 
damage observed in those patients.
The presence of significantly increased IL-6 concen­
trations in the patients with subsequent ARDS/MOF 
was remarkable. This was also reflected by the striking 
correlation between the IL-6 level and the MOF score 
during the 2 weeks studied. Although the patients with 
an uncomplicated clinical course showed a normaliza­
tion of IL-6 in the second week, the release of IL-6 in the 
patients with ARDS/MOF remained abnormally high 
during this period. The same has been demonstrated in 
patients after major thermal injury6 and septic shock.37
We could not demonstrate any relevant correlation 
between the concentrations of the three cytokines. This
finding has also been reported previously,23,38 and there­
fore, our data support the concept that the production of 
these cytokines is regulated independently.38
In conclusion, after major trauma, hemorrhagic shock 
caused by a ruptured AAA, or elective aortic aneurysm 
repair, increased concentrations of the cytokines TNF- 
a, IL-l/3, and IL-6 are a common finding. The higher 
concentrations found in the early postinjury time course 
are associated, not only with increased mortality rates, 
but also with an increased risk for the development of 
ARDS and MOF. The present study therefore supports 
the concept that ARDS and MOF are syndromes caused 
by an excessive uncontrolled activation of endogenous 
inflammatory cells and mediators.1
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